Abstract
There is evidence for a relationship between problematic cannabis use and depression although the directionality is unclear. The role of coping strategies mediating this relationship is of interest to better understand the mechanisms involved. The aim was to analyze the relationship between cannabis use and depression and its directionality, considering the mediating role of coping styles and their dependence on sex. Correlational and cross-sectional design. There were 261 cannabis users aged 18–57 years (M = 31.04), 36.66% women. Sex, cannabis dependence, coping styles, and depressive symptomatology were analyzed. Women scored higher in depression and men reported higher cannabis use, with a higher prevalence for moderate addiction. Higher severity of depressive symptomatology was found in cannabis users with dependence compared to those with moderate addiction. Active coping strategies were more common in the non-addicted group, while avoidant coping strategies were more common in the dependent group. The role of coping styles was observed to differ according to sex. In men, the relationship between depression and cannabis use was bidirectional, but the predictive capacity of each variable with respect to the others disappeared when considering avoidant coping as a mediator. Passive coping style is key in the relationship between depression and cannabis use. These findings have important implications for prevention and treatment of both problems.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agrawal, A., & Lynskey, M. T. (2014). Cannabis controversies: How genetics can inform the study of comorbidity. Addiction, 109(3), 360–370. https://doi.org/10.1111/add.12436
Amado, B. G., Villanueva, V. J., Vidal-Infer, A., & Isorna, M. (2020). Gender differences among cannabis self-cultivators in Spain. Adicciones, 32(3), 181–192. https://doi.org/10.20882/adicciones.1142
American Psychiatric Association. (2002). Manual diagnóstico y estadístico de los trastornos mentales (DSM-IV-TR). Masson.
Arnold, S. R., Uljarević, M., Hwang, Y. I., Richdale, A. L., Trollor, J. N., & Lawson, L. P. (2020). Brief report: Psychometric properties of the patient health Questionaire-9 (PHQ-9) in autistic adults. Journal of Autism and Developmental Disorders, 50, 2217–2225. https://doi.org/10.1007/s10803-019-03947-9
Baader, T., Molina, J. L., Venezian, S., Rojas, C., Farías, R., Fierro-Freixenet, C., Backenstrass, M., & Mundt, C. (2012). Validity and utility of PHQ9 (Patient Helth Questionnaire) in the diagnosis of depression in user patients of primary care in Chile. Revista Chilena De Neuropsiquiatría, 50(1), 10–22. https://doi.org/10.4067/S0717-92272012000100002
Baron, R. M., & Kenny, D. A. (1986). The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51(6), 1173–1182.
Becker, J. B., & Chartoff, E. (2018). Sex differences in neural mechanisms mediating reward and addiction. Neuropsychopharmacology, 44(1), 166–183. https://doi.org/10.1038/s41386-018-0125-6
Becker, J. B., McClellan, M. L., & Reed, B. G. (2017). Sex differences, gender and addiction. Journal of Neuroscience Research, 95(1–2), 136–147. https://doi.org/10.1002/jnr.23963.
Bélanger, E., Thomas, K. S., Jones, R. N., Epstein-Lubow, G., & Mor, V. (2019). Measurement validity of the Patient-Health Questionnaire-9 in US nursing home residents. International Journal of Geriatric Psychiatry, 34(5), 700–708. https://doi.org/10.1002/gps.5074
Bolanis, D., Orri, M., Castellanos-Ryan, N., Renaud, J., Montreuil, T., Boivin, M., ... , Geoffroy, M. C. (2020). Cannabis use, depression and suicidal ideation in adolescence: Direction of associations in a population based cohort. Journal of Affective Disorders, 274, 1076–1083. https://doi.org/10.1016/j.jad.2020.05.136
Boothroyd, L., Dagnan, D., & Muncer, S. (2019). PHQ-9: One factor or two? Psychiatry Research, 271, 532–534. https://doi.org/10.1016/j.psychres.2018.12.048
Brahim, S., Henia, M., Mohamed, A. H., Chabbouh, M., & Zarrouk, L. (2022). Anxiety and depression disorder among young cannabis users in Tunisia. European Psychiatry, 65(S1), S829–S829. https://doi.org/10.1192/j.eurpsy.2022.2147
Bright, U., & Akirav, I. (2022). Modulation of endocannabinoid system components in depression: Pre-clinical and clinical evidence. International Journal of Molecular Sciences, 23(10), 5526. https://doi.org/10.3390/ijms23105526
Budney, A. J., & Borodovsky, J. T. (2017). The potential impact of cannabis legalization on the development of cannabis use disorders. Preventive Medicine, 104, 31–36. https://doi.org/10.1016/j.ypmed.2017.06.034
Bujarski, S. J., Norberg, M. M., & Copeland, J. (2012). The association between distress tolerance and cannabis use-related problems: The mediating and moderating roles of coping motives and gender. Addictive Behaviors, 37(10), 1181–1184. https://doi.org/10.1016/j.addbeh.2012.05.014
Cao, H., Zhang, R., Li, L., & Yang, L. (2022). Coping style and resilience mediate the effect of childhood maltreatment on mental health symptomology. Children, 9(8), 1118. https://doi.org/10.3390/children9081118
Carrà, G., Bartoli, F., & Crocamo, C. (2019). Trends of major depressive episode among people with cannabis use: Findings from the national survey on drug use and health 2006-2015. Substance Abuse, 40(2), 178–184. https://doi.org/10.1080/08897077.2018.1550464
Casajuana, C., López-Pelayo, H., Oliveras, C., Colom, J., Gual, A., & Balcells-Oliveró, M. M. (2021). Relación entre las motivaciones para consumir y el consumo problemático de cannabis. Adicciones, 33(1), 31–42. https://doi.org/10.20882/adicciones.1221
Cash, M. C., Cunnane, K., Fan, C., & Romero-Sandoval, E. A. (2020). Mapping cannabis potency in medical and recreational programs in the United States. PLoS ONE, 15(3), e0230167. https://doi.org/10.1371/journal.pone.0230167
Cassiani-Miranda, C. A., Pérez-Aníbal, E., Vargas-Hernández, M. C., Herazo-Bustos, M., & Cabarcas-Tovar, A. (2018). Validez de apariencia y adaptación de la escala PHQ-9 para la detección de sintomatología depresiva en universitarios de ciencias de la salud de Cartagena (Colombia). Salud Uninorte, 34(1), 84–96. https://doi.org/10.14482/sun.34.1.9154
Cassiani-Miranda, C. A., Cuadros-Cruz, A. K., Torres-Pinzón, H., Scoppetta, O., Pinzón-Tarrazona, J. H., López-Fuentes, W. Y., ... , Llanes-Amaya, E. R. (2021). Validez del Cuestionario de salud del paciente-9 (PHQ-9) para cribado de depresión en adultos usuarios de Atención Primaria en Bucaramanga, Colombia. Revista Colombiana de Psiquiatría, 50(1), 11–21. https://doi.org/10.1016/j.rcp.2019.09.001
Chandra, S., Radwan, M. M., Majumdar, C. G., Church, J. C., Freeman, T. P., & ElSohly, M. A. (2019). New trends in cannabis potency in USA and Europe during the last decade (2008–2017). European Archives of Psychiatry and Clinical Neuroscience, 269(1), 5–15. https://doi.org/10.1007/s00406-019-00983-5
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021). Cannabis use and cannabis use disorder. Nature Reviews Disease Primers, 7(1), 16. https://doi.org/10.1038/s41572-021-00247-4
Costa, J., Simons, J., Pardo, M., Lleras, M., Pérez, A., & Andión, O. (2018). Spanish version validation of the marihuana motives measure in a drug-consuming adolescent sample. Adicciones, 30, 282–291. https://doi.org/10.20882/adicciones.947
Crane, N. A., Langenecker, S. A., & Mermelstein, R. J. (2015). Gender differences in the associations among marijuana use, cigarette use, and symptoms of depression during adolescence and young adulthood. Addictive behaviors, 49, 33–39.
Cuenca-Royo, A. M., Sanchez-Niubo, A., Forero, C. G., Torrens, M., Suelves, J. M., & Domingo-Salvany, A. (2012). Psychometric properties of the CAST and SDS scales in young adult cannabis users. Addictive Behaviors, 37, 709–715. https://doi.org/10.1016/j.addbeh.2012.02.012
Degenhardt, L., Hall, W., & Lynskey, M. (2003). Exploring the association between cannabis use and depression. Addiction, 98(11), 1493–1504. https://doi.org/10.1046/j.1360-0443.2003.00437.x
Degenhardt, L., Coffey, C., Romaniuk, H., Swift, W., Carlin, J. B., Hall, W. D., & Patton, G. C. (2013). The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction, 108(1), 124–133. https://doi.org/10.1111/j.1360-0443.2012.04015.x
Dellazizzo, L., Potvin, S., Beaudoin, M., Luigi, M., Dou, B. Y., Giguère, C. É., & Dumais, A. (2019). Cannabis use and violence in patients with severe mental illnesses: A meta-analytical investigation. Psychiatry Research, 274, 42–48. https://doi.org/10.1016/j.psychres.2019.02.010
Dierker, L., Selya, A., Lanza, S., Li, R., & Rose, J. (2018). Depression and marijuana use disorder symptoms among current marijuana users. Addictive Behaviors, 76, 161–168. https://doi.org/10.1016/j.addbeh.2017.08.013
Doi, S., Ito, M., Takebayashi, Y., Muramatsu, K., & Horikoshi, M. (2018). Factorial validity and invariance of the Patient Health Questionnaire (PHQ)-9 among clinical and non-clinical populations. PloS One, 13(7), e0199235. https://doi.org/10.1371/journal.pone.0199235
Eid, R. S., Gobinath, A. R., & Galea, L. A. (2019). Sex differences in depression: Insights from clinical and preclinical studies. Progress in Neurobiology, 176, 86–102. https://doi.org/10.1016/j.pneurobio.2019.01.006
Esmaeelzadeh, S., Moraros, J., Thorpe, L., & Bird, Y. (2018). Examining the association and directionality between mental health disorders and substance use among adolescents and young adults in the US and Canada -A systematic review and meta-analysis. Journal of Clinical Medicine, 7(12), 543. https://doi.org/10.3390/jcm7120543
European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]. (2018). Uso médico del cannabis y los cannabinoides: Preguntas y respuestas para la elaboración de políticas. Publications Office of the European Union. https://www.emcdda.europa.eu/system/files/publications/10171/20185584_TD0618186ESN_PDF.pdf
European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA]. (2021). European drug report 2021: Trends and developments. Publications Office of the European Union. https://www.emcdda.europa.eu/system/files/publications/13838/TDAT21001ENN.pdf
European Monitoring Centre for Drugs and Drug Addiction [EMCDDA]. (2022). European drug report 2022: Trends and developments. Publications Office of the European Union. https://www.emcdda.europa.eu/system/files/publications/14644/TDAT22001ENN.pdf
Farinha-Ferreira, M., Rei, N., Fonseca-Gomes, J., Miranda-Lourenço, C., Serrão, P., Vaz, S. H., ... , Sebastião, A. M. (2022). Unexpected short-and long-term effects of chronic adolescent HU-210 exposure on emotional behavior. Neuropharmacology, 214, 109155. https://doi.org/10.1016/j.neuropharm.2022.109155
Feingold, D., & Weinstein, A. (2021). Cannabis and depression. In: Murillo-Rodriguez, E., Pandi-Perumal, S.R., Monti, J.M. (eds) Cannabinoids and neuropsychiatric disorders. Advances in Experimental Medicine and Biology, vol 1264. Springer, Cham. https://doi.org/10.1007/978-3-030-57369-0_5
Finset, A., Steine, S., Haugli, L., Steen, E., & Laerum, E. (2002). The brief approach/avoidance coping questionnaire: Development and validation. Psychology, Health & Medicine, 7(1), 75–85. https://doi.org/10.1080/13548500120101577
Folkman, S., & Lazarus, R. S. (1980). An analysis of coping in a middle-aged community sample. Journal of Health and Social Behavior, 21(3), 219–239. https://www.jstor.org/stable/2136617.
Folkman, S., & Lazarus, R. S. (1988). Coping as a mediator of emotion. Journal of Personality and Social Psychology, 54(3), 466–475. https://doi.org/10.1037/0022-3514.54.3.466
Franklin, J. M., & Carrasco, G. A. (2013). Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT2A) receptor activity via ERK1/2 signaling. Synapse, 67(3), 145–159. https://doi.org/10.1002/syn.21626
Georgiades, K., & Boyle, M. H. (2007). Adolescent tobacco and cannabis use: Young adult outcomes from the Ontario Child Health Study. Journal of Child Psychology and Psychiatry, 48(7), 724–731. https://doi.org/10.1111/j.1469-7610.2007.01740.x
Gobbi, G., Atkin, T., Zytynski, T., Wang, S., Askari, S., Boruff, J., ... , Mayo, N. (2019). Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and meta-analysis. JAMA psychiatry, 76(4), 426–434. https://doi.org/10.1001/jamapsychiatry.2018.4500
González-Blanch, C., Medrano, L. A., Muñoz-Navarro, R., Ruíz-Rodríguez, P., Moriana, J. A., Limonero, J. T., ... , PsicAP Research Group. (2018). Factor structure and measurement invariance across various demographic groups and over time for the PHQ-9 in primary care patients in Spain. PloS One, 13(2), e0193356. https://doi.org/10.1371/journal.pone.0193356
Gunn, R. L., Jackson, K. M., Borsari, B., & Metrik, J. (2018). Negative urgency partially accounts for the relationship between major depressive disorder and marijuana problems. Borderline Personality Disorder and Emotion Dysregulation, 5(10), 1–8. https://doi.org/10.1186/s40479-018-0087-7
Hart-Hargrove, L. C., & Dow-Edwards, D. L. (2012). Withdrawal from THC during adolescence: Sex differences in locomotor activity and anxiety. Behavioural Brain Research, 231, 48–59. https://doi.org/10.1016/j.bbr.2012.02.048
Hartung, C. M., & Lefler, E. K. (2019). Sex and gender in psychopathology: DSM–5 and beyond. Psychological Bulletin, 145(4), 390–409. https://doi.org/10.1037/bul0000183
Hasin, D., & Walsh, C. (2020). Cannabis use, cannabis use disorder, and comorbid psychiatric illness: A narrative review. Journal of Clinical Medicine, 10(1), 15. https://doi.org/10.3390/jcm10010015
Hayes, A. F. (2013). Introduction to mediation, moderation and conditional process analysis. The Guilford Press.
Hoffmann, J. P. (2018). Marijuana use and depressive symptoms among young people: Examining unidirectional and bidirectional effects. Health, 10(8), 1066–1078. https://doi.org/10.4236/health.2018.108080
Hooshmand, S., Willoughby, T., & Good, M. (2012). Does the direction of effects in the association between depressive symptoms and health-risk behaviors differ by behavior? A longitudinal study across the high school years. Journal of Adolescent Health, 50(2), 140–147. https://doi.org/10.1016/j.jadohealth.2011.05.016
Instituto Nacional de Estadística [INE]. (2019). Encuesta sobre equipamiento y uso de tecnologías de información y comunicación en los hogares. https://www.ine.es/prensa/tich_2019.pdf
Isorna, M., Burillo-Putze, G., & Jose Villanueva-Blasco, V. (2022). Captura corporativa, fake news procannabis y posición de los consumidores ante su regulación. Global Health Promotion, 0(0), 1-10. https://doi.org/10.1177/17579759221107604
Jenkins, B. W., & Khokhar, J. Y. (2021). Cannabis use and mental illness: Understanding circuit dysfunction through preclinical models. Frontiers in Psychiatry, 12, 597725. https://doi.org/10.3389/fpsyt.2021.597725
Keith, D. R., Hart, C. L., McNeil, M. P., Silver, R., & Goodwin, R. D. (2015). Frequent marijuana use, binge drinking and mental health problems among undergraduates. American Journal on Addictions, 24, 499–506. https://doi.org/10.1111/ajad.12201
Kerridge, B. T., Pickering, R., Chou, P., Saha, T. D., & Hasin, D. S. (2018). DSM-5 cannabis use disorder in the national epidemiologic survey on alcohol and related conditions-III: Gender-specific profiles. Addictive Behaviors, 76, 52–60.
Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence [case reports research support, U.S. Gov’t, P.H.S. review]. American Journal of Psychiatry, 142(11), 1259–1264.
Klempova, D., Sánchez, A., Vicente, J., Barrio, G., Domingo, A., Suelves, J. M., … , Ramírez, V. (2009). Consumo problemático de cannabis en estudiantes españoles de 14 a 18 años: Validación de escalas. Madrid: Delegación del Gobierno para el Plan Nacional sobre Drogas. Ministerio de Sanidad y Política Social. Centro de Publicaciones.
Krebs, M. O., Kebir, O., & Jay, T. M. (2019). Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders. European Journal of Pain, 23(7), 1225–1233. https://doi.org/10.1002/ejp.1377
Kroenke, K., & Spitzer, R. L. (2002). The PHQ-9: A new depression diagnostic and severity measure. Psychiatric Annals, 32(9), 509–515. https://doi.org/10.3928/0048-5713-20020901-06
Kuehner, C. (2016). Why is depression more common among women than among men? The Lancet Psychiatry, 4(2), 146–158. https://doi.org/10.1016/S2215-0366(16)30263-2
Lamela, D., Soreira, C., Matos, P., & Morais, A. (2020). Systematic review of the factor structure and measurement invariance of the patient health questionnaire-9 (PHQ-9) and validation of the Portuguese version in community settings. Journal of Affective Disorders, 276, 220–233. https://doi.org/10.1016/j.jad.2020.06.066
Langlois, C., Potvin, S., Khullar, A., & Tourjman, S. V. (2021). Down and high: Reflections regarding depression and cannabis. Frontiers in Psychiatry, 12, 625158. https://doi.org/10.3389/fpsyt.2021.625158
Leadbeater, B. J., Ames, M. E., & Linden-Carmichael, A. N. (2019). Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. Addiction, 114(2), 278–293. https://doi.org/10.1111/add.14459
Legleye, S., Karila, L., Beck, F., & Reynaud, M. (2007). Validation of the CAST, a general population Cannabis Abuse Screening Test. Journal of Substance Use, 12, 233–242. https://doi.org/10.1080/14659890701476532
Leweke, F. M., & Koethe, D. (2008). Cannabis and psychiatric disorders: It is not only addiction. Addiction Biology, 13(2), 264–275. https://doi.org/10.1111/j.1369-1600.2008.00106.x
Ley Orgánica. (2018, March). De 5 de diciembre, de protección de datos personales y garantía de derechos digitales [spanish organic law 3/2018, September 5, on personal data protection and digital rights guarantee]. Boletín Oficial del Estado, núm. 294, del 6 de diciembre de 2018. https://www.boe.es/eli/es/lo/2018/12/05/3
Low, N. C., Dugas, E., O’Loughlin, E., Rodriguez, D., Contreras, G., Chaiton, M., & O’Loughlin, J. (2012). Common stressful life events and difficulties are associated with mental health symptoms and substance use in young adolescents. BMC Psychiatry, 12, 1–10. https://doi.org/10.1186/1471-244X-12-116
Márquez-Arrico, J. E., & Adan, A. (2016). Personality in patients with substance use disorders according to the co-occurring severe mental illness: A study using the alternative five factor model. Personality and Individual Differences, 97, 76–81. https://doi.org/10.1016/j.paid.2016.03.028
McHugh, R. K., Votaw, V. R., Sugarman, D. E., & Greenfield, S. F. (2018). Sex and gender differences in substance use disorders. Clinical Psychology Review, 66, 12–23. https://doi.org/10.1016/j.cpr.2017.10.012
Mennis, J., McKeon, T. P., & Stahler, G. J. (2023). Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults. Addictive Behaviors, 138, 107552. https://doi.org/10.1016/j.addbeh.2022.107552
Mohammad, G. S., Joca, S., & Starnawska, A. (2022). The cannabis-induced epigenetic regulation of genes associated with major depressive disorder. Genes, 13(8), 1435. https://doi.org/10.3390/genes13081435
Moitra, E., Christopher, P. P., Anderson, B. J., & Stein, M. D. (2015). Coping-motivated marijuana use correlates with DSM-5 cannabis use disorder and psychological distress among emerging adults. Psychology of Addictive Behaviors, 29(3), 627–632. https://doi.org/10.1037/adb0000083
Moos, R. H., & Schaefer, J. A. (1984). The crisis of physical illness: An overview and conceptual approach. In En R. H. Moss (Ed.), Coping with physical illness 2: New perspectives (pp. 3–25). Plenum Press.
National Academies of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: National Academies Press.
Observatorio Español sobre Drogas [OEDA]. (2023). Encuesta sobre alcohol y drogas en España 1995-2022 [EDADES]. Delegación del Gobierno para el Plan Nacional sobre Drogas, Ministerio de Sanidad, Servicios sociales e Igualdad. https://pnsd.sanidad.gob.es/profesionales/sistemasInformacion/sistemaInformacion/encuestas_EDADES.htm
Pang, R. D., Farrahi, L., Glazier, S., Sussman, S., & Leventhal, A. M. (2014). Depressive symptoms, negative urgency and substance use initiation in adolescents. Drug & Alcohol Dependence, 144, 225–230. https://doi.org/10.1016/j.drugalcdep.2014.09.77
Park, J. Y., & Wu, L. T. (2017). Differences in behavioral health disorders and unmet treatment needs between medical marijuana users and recreational marijuana users: Results from a national adult sample. Drug and Alcohol Dependence, 180, 311–318. https://doi.org/10.1016/j.drugalcdep.2017.08.028
Paz, C., Mascialino, G., Adana-Díaz, L., Rodríguez-Lorenzana, A., Simbaña-Rivera, K., Gómez-Barreno, L., Troya, M., Paez, M. I., Cárdenas, J., Gerstner, R. M., & Ortiz-Prado, E. (2020). Behavioral and sociodemographic predictors of anxiety and depression in patients under epidemiological surveillance for COVID-19 in Ecuador. PloS One, 15(9), e0240008. https://doi.org/10.1371/journal.pone.0240008. Article.
Prat, G., Márquez-Arrico, J. E., Rio-Martinez, L., Navarro, J. F., & Adan, A. (2021). Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 110, 110310. https://doi.org/10.1016/j.pnpbp.2021.110310
Quigley, J. A., Logsdon, M. K., Turner, C. A., Gonzalez, I. L., Leonardo, N. B., & Becker, J. B. (2021). Sex differences in vulnerability to addiction. Neuropharmacology, 187, 108491. https://doi.org/10.1016/j.neuropharm.2021.108491
Rea, L. M., & Parker, R. A. (2014). Designing and conducting survey research: A comprehensive guide. John Wiley & Sons.
Riecher-Rössler, A., Butler, S., & Kulkarni, J. (2018). Sex and gender differences in schizophrenic psychoses—A critical review. Archives of Women’s Mental Health, 21, 627–648. https://doi.org/10.1007/s00737-018-0847-9
Rodríguez, F., Cebeira, M., Ramos, J. A., Martin, M., & Fernandez-Ruiz, J. J. (1994). Cannabinoid receptors in rat brain areas: Sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life sciences, 54(3), 159–170. https://doi.org/10.1016/0024-3205(94)00585-0
Sato, T. (2022). Interventions for co-occurring cannabis use and depression. Cureus Journal of Medical Science, 14(8), e27632. https://doi.org/10.7759/cureus.27632
Schepis, T. S., Desai, R. A., Cavallo, D. A., Smith, A. E., McFetridge, A, Liss, T. B., … , Krishnan-Sarin, S. (2011). Gender differences in adolescent marijuana use and associated psychosocial characteristics. Journal of Addiction Medicine, 5, 65–73. https://doi.org/10.1097/ADM.0b013e3181d8dc62
Schlienz, N. J., Budney, A. J., Lee, D. C. & Vandrey, R. (2017). Cannabis withdrawal: A review of neurobiological mechanisms and sex differences. Current Addiction Reports, 4, 75–81. https://doi.org/10.1007/s40429-017-0143-1
Torrens-Melich, M., Orengo, T., Rodríguez de Fonseca, F., Almodóvar, I., Baquero, A., & Benito, A. (2021). Gender perspective in dual diagnosis. Brain Sciences, 11(8), 1101. https://doi.org/10.3390/brainsci11081101
Twohig, M. P., Shoenberger, D., & Hayes, S. C. (2007). A preliminary investigation of acceptance and commitment therapy as a treatment for marijuana dependence in adults. Journal of Applied Behavior Analysis, 40(4), 619–632. https://doi.org/10.1901/jaba.2007.619-632
UNODC. (2020). World drug report 2020. UNODC Research.
Villalobos, A. (2009). Development of a resilience measure to establish the psychosocial profile of resilient adolescents that allows testing the explanatory model of resilience based on psychosocial variables. [Trabajo Fin de Grado, Universidad de Costa Rica]. Caja Costarricense de Seguro Social. https://www.binasss.sa.cr/bibliotecas/bhp/textos/tesis11.pdf
Villanueva-Blasco, V. J., Villanueva-Silvestre, V., Vázquez-Martínez, A., de Vicente, L. P., & Pérez-Gálvez, B. (2022a). Depression, suicidal ideation, and consumption of psychotropic drugs during lockdown by COVID-19 according to gender and age. International Journal of Mental Health and Addiction, 1–17. https://doi.org/10.1007/s11469-022-00962-3
Villanueva-Blasco, V. J., Villanueva-Silvestre, V., Vázquez-Martínez, A., Fernández, V. A., & Isorna, M. (2022b). Cannabis use in young and adult university students before and during the COVID-19 lockdown, according to gender and age. International Journal of Mental Health and Addiction, 1–13. https://doi.org/10.1007/s11469-022-00991-y
Villanueva-Blasco, V.J., Mateu-Mollá, J., Villanueva-Silvestre, V. & Vázquez-Martínez, A. (2022c). Relationship between depression and risky alcohol consumption in women: The mediating role of coping styles and age. International Journal of Mental Health and Addiction, 1–18. https://doi.org/10.1007/s11469-022-00931-w
Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. The Lancet, 370(9596), 1453–1457.
White, C. T., Shamim, H., Al Shouli, R., Habbal, A. B., & Mohammed, L. (2022). Cannabis use and the development of depression in adolescents: Is there an established linear relationship between the two?. Cureus, 14(7). https://doi.org/10.7759/cureus.27394
Womack, S. R., Shaw, D. S., Weaver, C. M., & Forbes, E. E. (2016). Bidirectional associations between cannabis use and depressive symptoms from adolescence through early adulthood among at-risk young men. Journal of Studies on Alcohol and Drugs, 77(2), 287–297.
Zhang, Y., Huang, L., Luo, Y., & Ai, H. (2021). The relationship between state loneliness and depression among youths during COVID-19 lockdown: Coping style as mediator. Frontiers in Psychology, 12, 701514. https://doi.org/10.3389/fpsyg.2021.701514
Zhu, H., & Wu, L. T. (2017). Sex differences in cannabis use disorder diagnosis involved hospitalizations in the United States. Journal of Addiction Medicine, 11(5), 357. https://doi.org/10.1097/ADM.0000000000000330
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests. Funding this work was supported by Valencian International University [PII2020_05], Delegación del Gobierno para el Plan Nacional sobre Drogas [2021I062], and “Instituto de Salud Carlos III”, Red de Investigación en Atención Primaria de Adicciones [RIAPAd; grant RD21/0009/0015] [RIAPAd; grant RD21/0009/0012] [RIAPAd; grant RD21/0009/0003].
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Villanueva-Blasco, V.J., Mateu-Mollá, J., Vázquez-Martínez, A. et al. The Role of Sex and Coping Styles on the Relationship Between Depression and Cannabis Use. Int J Ment Health Addiction (2024). https://doi.org/10.1007/s11469-024-01275-3
Accepted:
Published:
DOI: https://doi.org/10.1007/s11469-024-01275-3